UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Investigational new drugs, 2018-12, Vol.36 (6), p.1060-1071

2018

Volltextzugriff (PDF)

Abstract CT045: Phase 1, open-label, first-in-human study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT045-CT045

2016

Volltextzugriff (PDF)

A first-in-human study of AMG 780, an angiopoietin-1 and -2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2542-2542

2014

Volltextzugriff (PDF)

Evaluation of pharmacokinetic (PK) drug-drug interactions (DDI) between trebananib (AMG 386) and paclitaxel (PTX) in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2584-2584

2014

Volltextzugriff (PDF)

First-in-human study of AMG 900, an oral pan-Aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.3009-3009

2012

Volltextzugriff (PDF)

An EGFRvIII-specific IHC IUO test for patient selection in AMG 595 phase I trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2071-2071

2013

Volltextzugriff (PDF)

Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques

PLoS pathogens, 2017-08, Vol.13 (8), p.e1006487-e1006487

2017

Volltextzugriff (PDF)

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

The New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381

2021

Volltextzugriff (PDF)

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections

PLoS pathogens, 2021-01, Vol.17 (1), p.e1009240-e1009240

2021

Volltextzugriff (PDF)

Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques

PLoS neglected tropical diseases, 2020-04, Vol.14 (4), p.e0008191-e0008191

2020

Volltextzugriff (PDF)

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

The Lancet infectious diseases, 2024-08, Vol.24 (8), p.896-908

2024

Volltextzugriff (PDF)

Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection

Frontiers in immunology, 2021-11, Vol.12, p.777672-777672

2021

Volltextzugriff (PDF)

Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial

The Journal of infectious diseases, 2021-05, Vol.223 (10), p.1707-1716

2021

Volltextzugriff (PDF)

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells

The Journal of immunology (1950), 2018-12, Vol.201 (12), p.3804-3814

2018

Volltextzugriff (PDF)

Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations

Circulation, 2010-10, Vol.122 (16 Suppl 2), p.S345-S421

2010

Volltextzugriff (PDF)

Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1843-1851

2013

Volltextzugriff (PDF)

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

The New England journal of medicine, 2020-09, Vol.383 (13), p.1207-1217

2020

Volltextzugriff (PDF)

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.247-247.5

2020

Volltextzugriff (PDF)

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques

npj vaccines, 2021-05, Vol.6 (1), p.77-77, Article 77

2021

Volltextzugriff (PDF)

Multiplexed FluoroSpot for the Analysis of Dengue and Zika Virus Specific and Cross-Reactive Memory B-cells

The Journal of immunology (1950), 2018-11, Vol.201 (12), p.3804-3814

2018

Volltextzugriff (PDF)

Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428

Diabetes (New York, N.Y.), 2017-09, Vol.66 (9), p.2531-2531

2017

Volltextzugriff (PDF)

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

Blood, 2013-11, Vol.122 (21), p.678-678

2013

Volltextzugriff (PDF)

Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?

Nature clinical practice. Oncology, 2006-05, Vol.3 (5), p.240-241

2006

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Abstract CT045: Phase 1, open-label, first-in-human study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors

A first-in-human study of AMG 780, an angiopoietin-1 and -2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors

Evaluation of pharmacokinetic (PK) drug-drug interactions (DDI) between trebananib (AMG 386) and paclitaxel (PTX) in patients (pts) with advanced solid tumors

First-in-human study of AMG 900, an oral pan-Aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors

An EGFRvIII-specific IHC IUO test for patient selection in AMG 595 phase I trial

Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections

Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection

National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities

Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells

Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations

Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques

Multiplexed FluoroSpot for the Analysis of Dengue and Zika Virus Specific and Cross-Reactive Memory B-cells

Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?

Suchergebnisse filtern